Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Pheniramine maleate

Copy Product Info
🥰Excellent
Catalog No. T0370Cas No. 132-20-7
Alias Trimetose, Inhiston, Daneral

Pheniramine maleate (Trimetose), an alkylamine derivative with antihistaminic and vasodilatory properties, binds to histamine H1 receptors, thereby inhibiting phospholipase A2 and production of the endothelium-derived relaxing factor, nitric oxide.

Pheniramine maleate

Pheniramine maleate

Copy Product Info
🥰Excellent
Purity: 99.85%
Catalog No. T0370Alias Trimetose, Inhiston, DaneralCas No. 132-20-7
Pheniramine maleate (Trimetose), an alkylamine derivative with antihistaminic and vasodilatory properties, binds to histamine H1 receptors, thereby inhibiting phospholipase A2 and production of the endothelium-derived relaxing factor, nitric oxide.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
100 mg$34In StockIn Stock
500 mg$73In StockIn Stock
1 g$96In StockIn Stock
1 mL x 10 mM (in DMSO)$39In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.85%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Pheniramine maleate (Trimetose), an alkylamine derivative with antihistaminic and vasodilatory properties, binds to histamine H1 receptors, thereby inhibiting phospholipase A2 and production of the endothelium-derived relaxing factor, nitric oxide.
Targets&IC50
H1 Receptor:1.01 mM
In vivo
Pheniramine maleate binds to histamine H1 receptors, which inhibits the production of phospholipase A2 and the endothelium-derived relaxing factor NO. This leads to a reduction in the activation of guanylate cyclase due to NO deficiency, resulting in decreased levels of cyclic GMP (cGMP). Consequently, this suppresses the contraction of smooth muscle tissues, reduces capillary permeability, and diminishes histamine-induced allergic responses.
SynonymsTrimetose, Inhiston, Daneral
Chemical Properties
Molecular Weight356.42
FormulaC16H20N2·C4H4O4
Cas No.132-20-7
SmilesCN(C)CCC(c1ccccc1)c1ccccn1.C(=C\C(=O)O)\C(=O)O
Relative Density.1.2233 g/cm3 (Estimated)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: 65 mg/mL (182.37 mM), Sonication is recommended.
Ethanol: 66 mg/mL (185.17 mM), Sonication is recommended.
DMSO: 40 mg/mL (112.23 mM), Sonication is recommended.
Solution Preparation Table
DMSO/H2O/Ethanol
1mg5mg10mg50mg
1 mM2.8057 mL14.0284 mL28.0568 mL140.2839 mL
5 mM0.5611 mL2.8057 mL5.6114 mL28.0568 mL
10 mM0.2806 mL1.4028 mL2.8057 mL14.0284 mL
20 mM0.1403 mL0.7014 mL1.4028 mL7.0142 mL
50 mM0.0561 mL0.2806 mL0.5611 mL2.8057 mL
100 mM0.0281 mL0.1403 mL0.2806 mL1.4028 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Pheniramine maleate | purchase Pheniramine maleate | Pheniramine maleate cost | order Pheniramine maleate | Pheniramine maleate chemical structure | Pheniramine maleate in vivo | Pheniramine maleate formula | Pheniramine maleate molecular weight